High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer
Open Access
- 18 June 2019
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 19 (1) , 1-8
Abstract
Enhanced glycolysis in tumors, known as the Warburg effect, provides the metabolic basis of enhanced cancer cell proliferation and metastasis. The Warburg pathway enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is a newly identified key kinase that regulates transcriptional reprogramming and cell proliferation. Here we show the prognostic value of PFKFB4 expression in patients with operable breast cancer. PFKFB4 expression was evaluated by immunohistochemistry in surgical specimens retrospectively collected from 200 patients with histologically proven invasive ductal breast cancer. Kaplan–Meier survival analysis and Cox regression analysis were performed to assess the prognostic significance of PFKFB4 expression. Kaplan–Meier survival analysis revealed that breast cancer patients with high PFKFB4 expression demonstrated unfavorable disease-free survival (p = 0.008) and overall survival (p = 0.002). PFKFB4 had an hazard ratio (HR) of 7.38 (95% CI 1.69–32.3; p = 0.008) in univariate Cox analysis and retained prognostic power (HR 7.44, 95% CI 1.67–33.2; p = 0.009) when adjusted by tumor size, lymph node status, grade, estrogen receptor status, human epidermal growth factor receptor 2 status and subtype, which indicated PFKFB4 was an independent prognostic factor in breast cancer. Together, our findings establish the prognostic value of metabolic enzyme PFKFB4 in patients with operable breast cancer.Keywords
This publication has 19 references indexed in Scilit:
- MCT4 Defines a Glycolytic Subtype of Pancreatic Cancer with Poor Prognosis and Unique Metabolic DependenciesCell Reports, 2014
- The endoplasmic reticulum stress markers GRP78 and CHOP predict disease-free survival and responsiveness to chemotherapy in breast cancerBreast Cancer Research and Treatment, 2014
- A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic PotentialClinical Cancer Research, 2014
- PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancerUrologic Oncology: Seminars and Original Investigations, 2012
- Functional Metabolic Screen Identifies 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 4 as an Important Regulator of Prostate Cancer Cell SurvivalCancer Discovery, 2012
- Cancer Cell Metabolism: There Is No ROS for the WearyCancer Discovery, 2012
- RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survivalOncogene, 2011
- Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic TransformationCancer Cell, 2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growthNature, 2008